Detalhe da pesquisa
1.
Testosterone treatment and change of categories of the International prostate symptom score (IPSS) in hypogonadal patients: 12 years prospective controlled registry study.
Aging Male
; 26(1): 2220567, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37287273
2.
Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: a prospective controlled registry study.
Aging Male
; 23(5): 1553-1563, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439074
3.
Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size.
Int Urol Nephrol
; 55(7): 1649-1658, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148486
4.
Long-Term Performance of the Magmaris Drug-Eluting Bioresorbable Metallic Scaffold in All-Comers Patients' Population.
J Clin Med
; 11(13)2022 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35807011
5.
Long-term outcome of first 300 implanted Absorb bioresorbable vascular scaffolds in an all-comers Middle East population.
J Int Med Res
; 47(1): 173-187, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30235969